InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Browse the complete record of transactions filed by Cohen Chad M, Chief Financial Officer. Insider active across 2 companies, notably Adaptive Biotechnologies Corp. Cumulatively, 17 reports have been logged. The latest transaction was disclosed on 24 May 2022 (Attribution). Regulator: SEC (Form 4). All data is free.
Declarations17 total
033,999 shares0
Class A Common Stock
SEC:0001874944-22-000028:0·
€64,40710,000 shares@ €6.44070.0031% mcap17.4% of flow
Common Stock
SEC:0001209191-21-071193·
€64,40710,000 shares@ €6.44070.0031% mcap8.7% of flow
Common Stock
SEC:0001209191-21-071193:0·
€31,3595,000 shares@ €6.27180.0015% mcap8.5% of flow
Common Stock
SEC:0001209191-21-064253·
€31,3595,000 shares@ €6.27180.0015% mcap4.2% of flow
Common Stock
SEC:0001209191-21-064253:0·
€31,3475,000 shares@ €6.26940.0015% mcap8.5% of flow
Common Stock
SEC:0001209191-21-059985·
€31,3475,000 shares@ €6.26940.0015% mcap4.2% of flow
Common Stock
SEC:0001209191-21-059985:0·
€51,8489,375 shares@ €5.53040.0025% mcap14.0% of flow
Common Stock
SEC:0001209191-21-055368·
€51,8489,375 shares@ €5.53040.0025% mcap7.0% of flow
Common Stock
SEC:0001209191-21-055368:0·
€27,9365,000 shares@ €5.58710.0014% mcap7.5% of flow
Common Stock
SEC:0001209191-21-051275·
€27,9365,000 shares@ €5.58710.0014% mcap3.8% of flow
Common Stock
SEC:0001209191-21-051275:0·
€55,39310,000 shares@ €5.53930.0027% mcap15.0% of flow
Common Stock
SEC:0001209191-21-046082·
€55,39310,000 shares@ €5.53930.0027% mcap7.5% of flow
Common Stock
SEC:0001209191-21-046082:0·
€53,80810,000 shares@ €5.38080.0026% mcap14.5% of flow
Common Stock
SEC:0001209191-21-039637·
€53,80810,000 shares@ €5.38080.0026% mcap7.3% of flow
Common Stock
SEC:0001209191-21-039637:0·
€53,93410,000 shares@ €5.39340.0026% mcap14.6% of flow
Common Stock
SEC:0001209191-21-032438·
€53,93410,000 shares@ €5.39340.0026% mcap7.3% of flow
Common Stock
SEC:0001209191-21-032438:0·
17 of 17 declarations
About Cohen Chad M
Chad M Cohen is an executive at Adaptive Biotechnologies Corp.
